Prophylactic drugs are effective for migraine prevention in patients unresponsive to traditional treatments, suggesting a new option.
The new prophylactic drugs against migraine are effective, well-tolerated, and especially useful for patients for whom traditional oral migraine prophylactic drugs and onabotulinum toxin A are ineffective, not tolerated, or contraindicated.
No takes yet. Share an insight, caveat, or question.
Diener et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: